Effector domain of influenza a/pr/8/34 ns1 Deposition Author(s): Hale, B.G. , Hass, C. , Kerry, P.S. , Lewis, A. , Randall, R.E. , Russell, R.J.M. , Taylor, M.A.
Date: 2010-08-04 Method: X-RAY DIFFRACTION Resolution: 3.2 Å Organism(s): Influenza A Virus Sequences Data: 3O9U_B , 3O9U_A , 3O9U_C , 3O9U_D , 3O9U_E , 3O9U_F , 3O9U_G , 3O9U_H
Effector domain of influenza a/duck/albany/76 ns1 Deposition Author(s): Hale, B.G. , Hass, C. , Kerry, P.S. , Lewis, A. , Randall, R.E. , Russell, R.J.M. , Taylor, M.A.
Date: 2010-08-05 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Influenza A Virus Sequences Data: 3OA9_A , 3OA9_B
Effector domain of ns1 from influenza a/pr/8/34 containing a w187a mutation Deposition Author(s): Kerry, P.S. , Long, E. , Russell, R.J.M. , Taylor, M.A.
Date: 2011-05-06 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Influenza A Virus Sequences Data: 3RVC_A
Influenza na in complex with antiviral compound Deposition Author(s): Kerry, P.S. , Russell, R.J.M.R.
Date: 2012-01-11 Method: X-RAY DIFFRACTION Resolution: 2.398 Å Organism(s): Influenza A Virus Sequences Data: 4D8S_A
Synthesis and evaluation of novel 3-c-alkylated-neu5ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility Deposition Author(s): Dyason, J.C. , Kerry, P.S. , Maggioni, A. , Naffakh, N. , Rameix-Welti, M.-A. , Rose, F.J. , Rudrawar, S. , Russell, R.J.M. , Thomson, R.J. , Van Der Werf, S. , Von Itzstein, M.
Date: 2012-07-26 Method: X-RAY DIFFRACTION Resolution: 2.62 Å Organism(s): Influenza A Virus Sequences Data: 4GB1_A
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid Deposition Author(s): Kerry, P.S. , Russell, R.J.M.
Date: 2013-05-17 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Influenza A Virus Sequences Data: 4KS1_A
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-carbamimidamido-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid Deposition Author(s): Kerry, P.S. , Russell, R.J.M.
Date: 2013-05-17 Method: X-RAY DIFFRACTION Resolution: 2.595 Å Organism(s): Influenza A Virus Sequences Data: 4KS2_A
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-[4-(3-hydroxypropyl)-1h-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid Deposition Author(s): Kerry, P.S. , Russell, R.J.M.
Date: 2013-05-17 Method: X-RAY DIFFRACTION Resolution: 2.6 Å Organism(s): Influenza A Virus Sequences Data: 4KS3_A
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-{4-[(1r)-1-hydroxypropyl]-1h-1,2,3-triazol-1-yl}-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid Deposition Author(s): Kerry, P.S. , Russell, R.J.M.
Date: 2013-05-17 Method: X-RAY DIFFRACTION Resolution: 2.495 Å Organism(s): Influenza A Virus Sequences Data: 4KS4_A
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-[4-(2-hydroxypropan-2-yl)-1h-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid Deposition Author(s): Kerry, P.S. , Russell, R.J.M.
Date: 2013-05-17 Method: X-RAY DIFFRACTION Resolution: 2.699 Å Organism(s): Influenza A Virus Sequences Data: 4KS5_A